Hospitalist Doctors in Middletown, OH Accepting Medicare

7 Hospitalist doctors found. Showing 1 - 7

Komal Tariq, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6730 Roosevelt Ave Ste 303, Middletown, OH 45005 Phone: 513-874-0486    Fax: 513-280-8868

Mr. Chirag Ashvin Shah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6730 Roosevelt Ave Ste 303, Middletown, OH 45005 Phone: 513-874-0486    Fax: 513-280-8868

Dr. Franklin Cornelius Mikell, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Middletown, OH 45005 Phone: 513-705-4754    Fax: 513-420-5156

Harmanpreet Singh Shinh, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Cogent Hmg Hospitalist Office, Middletown, OH 45005 Phone: 302-824-5381

Dr. Ravikanth Chanda, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6730 Roosevelt Ave Ste 303, Middletown, OH 45005 Phone: 513-874-0486    Fax: 513-280-8868

Dr. Bhanu Prakash Yadiki, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6730 Roosevelt Ave Ste 303, Middletown, OH 45005 Phone: 513-874-0486

Pavani Dantala, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Middletown, OH 45005 Phone: 513-705-4754    Fax: 513-420-5156

News Archive

DePuy Synthes receives European CE Mark for new BI-MENTUMTM Dual Mobility System

Johnson & Johnson Medical Devices Companies today announces that DePuy Synthes, a leader in the cementless hip implant market, has obtained the European CE Mark on its new BI-MENTUMTM Dual Mobility System for use in patients with a higher risk of dislocation.

Cellular Biomedicine Group completes TC-DC Phase I clinical trial for hepatocellular carcinoma

Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.

GE Healthcare, Ascom collaborate to launch wireless hospital-wide messaging system

GE Healthcare and Ascom Wireless Solutions today released plans to launch a wireless hospital-wide messaging system, to improve workflow and communication for healthcare providers. The agreement aligns the GE Healthcare patient monitoring platform with Ascom's wireless communication solutions to enable hospitals to customize, filter and send secondary alarms to clinicians' Ascom Voice over IP (VoIP) phones, pagers and Digital Enhanced Cordless Telecommunications (DECT) handsets.

EU-funded project is developing new tools for diagnosing cancer

Proteins are the basis of cellular and physiological functioning in living organisms. The physical and chemical properties of proteins determine how they act and work within cells.

Kyto Biopharma signs licensing agreement with RFSUNY, gains patent rights to Transcobalamin Receptor

Kyto Biopharma Inc., is pleased to announce that it has signed a licensing agreement with the Research Foundation of the State University of New York. The licensing agreement grants Kyto patent rights to the Transcobalamin (Vitamin B12) Receptor and to an additional broad group of other patents which are critical to Kyto's research and development strategy for the treatment of cancer.

Read more Medical News

› Verified 8 days ago